These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30317535)

  • 21. Symptomatic and Preventive Medication Use before and after Alzheimer's Disease Diagnosis: A 10-Year Matched Cohort Study.
    Liau SJ; Bell JS; Lalic S; Tolppanen AM; Hartikainen S
    J Am Med Dir Assoc; 2024 Jul; 25(7):105012. PubMed ID: 38702043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
    Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
    Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease.
    Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Eur J Pain; 2017 Apr; 21(4):658-667. PubMed ID: 27862681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
    Taipale H; Rysä J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kröger H; Hartikainen S; Tolppanen AM
    Osteoporos Int; 2019 Jul; 30(7):1481-1489. PubMed ID: 30993395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
    Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study.
    Savolainen-Peltonen H; Rahkola-Soisalo P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O; Mikkola TS
    BMJ; 2019 Mar; 364():l665. PubMed ID: 30842086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Int Clin Psychopharmacol; 2015 Jul; 30(4):202-8. PubMed ID: 26011780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease.
    Lintula E; Tiihonen M; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Hamina A
    Drugs Aging; 2020 Mar; 37(3):193-203. PubMed ID: 31879863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
    Rajamaki B; Hartikainen S; Tolppanen AM
    BMC Geriatr; 2021 Mar; 21(1):173. PubMed ID: 33750334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland.
    Karttunen N; Taipale H; Hamina A; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
    Int J Geriatr Psychiatry; 2019 Feb; 34(2):280-288. PubMed ID: 30370943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?
    Hakala A; Tolppanen AM; Koponen M; Taipale H; Tanskanen A; Hartikainen S; Tiihonen M
    J Am Med Dir Assoc; 2021 Jul; 22(7):1543-1547.e3. PubMed ID: 33460619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease.
    Kettunen R; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Koponen M
    Eur J Clin Pharmacol; 2019 Mar; 75(3):417-425. PubMed ID: 30413841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease.
    Juntunen H; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Tiihonen M
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1149-1158. PubMed ID: 28577224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
    Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
    Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
    Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
    Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study.
    Koponen M; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Ahonen R; Hartikainen S
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1706-13. PubMed ID: 26233607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease.
    Tarvainen A; Hartikainen S; Taipale H; Tanskanen A; Koponen M; Tolppanen AM
    Int J Geriatr Psychiatry; 2021 Jul; 36(7):1075-1084. PubMed ID: 33527403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons.
    Koponen M; Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Johnell K; Fastbom J; Ahonen R; Hartikainen S
    Br J Psychiatry; 2015 Nov; 207(5):444-9. PubMed ID: 26450581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
    Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
    Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer's Disease.
    Heiskanen J; Hartikainen S; Roine RP; Tolppanen AM
    J Alzheimers Dis; 2015; 48(1):241-9. PubMed ID: 26401944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.